0
ARTICLE |

Fibrinolytics and Antifibrinolytics

David I. Abramson, MD
JAMA. 1979;242(15):1674-1675. doi:10.1001/jama.1979.03300150068039.
Text Size: A A A
Published online

ABSTRACT

This large volume on various aspects of fibrinolytics and antifibrinolytics is the composite work of 18 collaborators primarily from several countries in Europe. Its aim is to present more information about these substances and to make the various concepts regarding their mode of activity available not only to the research workers in the field of hematology but also to the clinicians involved in the treatment of patients suffering from bleeding disorders and intravascular clotting.

The monograph is composed of 14 articles divided in four sections—the fibrinolytic process (the largest part), the activators of fibrinolysis, the fibrinolytically active enzymes, and the antifibrinolytics. In the first section, emphasis is placed on how the fibrinolytic system is specifically adapted to the degradation of insoluble fibrin into soluble degradation products. Such knowledge is necessary for an understanding of the effects and side reactions of fibrinolytics and antifibrinolytics and for the clinical application of these

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs